These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29777661)

  • 1. Impact of Comorbidities on the Treatment of Chronic Obstructive Pulmonary Disease.
    Garvey C; Criner GJ
    Am J Med; 2018 Sep; 131(9S):23-29. PubMed ID: 29777661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
    Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
    Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing comorbidities in COPD.
    Hillas G; Perlikos F; Tsiligianni I; Tzanakis N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():95-109. PubMed ID: 25609943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary disease.
    Panagioti M; Scott C; Blakemore A; Coventry PA
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1289-306. PubMed ID: 25419126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index.
    Frei A; Muggensturm P; Putcha N; Siebeling L; Zoller M; Boyd CM; ter Riet G; Puhan MA
    J Clin Epidemiol; 2014 Aug; 67(8):904-11. PubMed ID: 24786594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COPD in Primary Care: Key Considerations for Optimized Management: Anxiety and Depression in Chronic Obstructive Pulmonary Disease: Recognition and Management.
    Yohannes AM; Kaplan A; Hanania NA
    J Fam Pract; 2018 Feb; 67(2 Suppl):S11-S18. PubMed ID: 29443332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, Contribution to Disease Burden and Management of Comorbid Depression and Anxiety in Chronic Obstructive Pulmonary Disease: A Narrative Review.
    Zareifopoulos N; Bellou A; Spiropoulou A; Spiropoulos K
    COPD; 2019 Dec; 16(5-6):406-417. PubMed ID: 31638445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.
    Vanfleteren LE; Spruit MA; Groenen M; Gaffron S; van Empel VP; Bruijnzeel PL; Rutten EP; Op 't Roodt J; Wouters EF; Franssen FM
    Am J Respir Crit Care Med; 2013 Apr; 187(7):728-35. PubMed ID: 23392440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidity in chronic obstructive pulmonary disease.
    Negewo NA; McDonald VM; Gibson PG
    Respir Investig; 2015 Nov; 53(6):249-58. PubMed ID: 26521102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical activity and risk of comorbidities in patients with chronic obstructive pulmonary disease: a cohort study.
    Yu T; Ter Riet G; Puhan MA; Frei A
    NPJ Prim Care Respir Med; 2017 May; 27(1):36. PubMed ID: 28522822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comorbidities in COPD: a new challenge in clinical practice].
    Couillard A; Veale D; Muir JF
    Rev Pneumol Clin; 2011 Jun; 67(3):143-53. PubMed ID: 21665077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment.
    Brenes GA
    Psychosom Med; 2003; 65(6):963-70. PubMed ID: 14645773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chronic obstructive pulmonary disease comorbidity spectrum in Japan differs from that in western countries.
    Takahashi S; Betsuyaku T
    Respir Investig; 2015 Nov; 53(6):259-70. PubMed ID: 26521103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidities of chronic obstructive pulmonary disease.
    Corsonello A; Antonelli Incalzi R; Pistelli R; Pedone C; Bustacchini S; Lattanzio F
    Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S21-8. PubMed ID: 22209926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression and anxiety in elderly patients with chronic obstructive pulmonary disease.
    Yohannes AM; Baldwin RC; Connolly MJ
    Age Ageing; 2006 Sep; 35(5):457-9. PubMed ID: 16638758
    [No Abstract]   [Full Text] [Related]  

  • 16. Depression, anxiety and chronic pain in patients with chronic obstructive pulmonary disease: the influence of breath.
    Bordoni B; Marelli F; Morabito B; Sacconi B
    Monaldi Arch Chest Dis; 2017 May; 87(1):811. PubMed ID: 28635197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic manifestations of COPD.
    Nussbaumer-Ochsner Y; Rabe KF
    Chest; 2011 Jan; 139(1):165-73. PubMed ID: 21208876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression.
    Cully JA; Graham DP; Stanley MA; Ferguson CJ; Sharafkhaneh A; Souchek J; Kunik ME
    Psychosomatics; 2006; 47(4):312-9. PubMed ID: 16844889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
    Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB
    COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Objectively identified comorbidities in COPD: impact on pulmonary rehabilitation outcomes.
    Mesquita R; Vanfleteren LE; Franssen FM; Sarv J; Taib Z; Groenen MT; Gaffron S; Bruijnzeel PL; Pitta F; Wouters EF; Spruit MA
    Eur Respir J; 2015 Aug; 46(2):545-8. PubMed ID: 26113670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.